Stay updated on Optimized Nivolumab Management Clinical Trial
Sign up to get notified when there's something new on the Optimized Nivolumab Management Clinical Trial page.

Latest updates to the Optimized Nivolumab Management Clinical Trial page
- Check5 days agoChange DetectedA new revision label 'Revision: v3.3.4' is shown, replacing the previous 'Revision: v3.3.3'.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedAdded study locations: California, Illinois, Massachusetts, North Carolina, Rhode Island, Utah, and Wisconsin, and updated the Locations section. The revision version moved from v3.3.2 to v3.3.3.SummaryDifference0.7%

- Check55 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all pertain to the study, and updated the revision tag to v3.3.2.SummaryDifference0.1%

- Check62 days agoChange DetectedThe funding lapse notice on the page has been removed. The previous notice warned that information may not be up to date and directed users to NIH CC status and opm.gov for updates.SummaryDifference0.3%

- Check84 days agoChange DetectedThe new screenshot shows no changes to core study information such as interventions or eligibility; only minor UI/layout adjustments are visible.SummaryDifference0.4%

- Check105 days agoChange DetectedMajor change: updated operating status notice and version to v3.2.0; removed v3.1.0.SummaryDifference2%

Stay in the know with updates to Optimized Nivolumab Management Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Optimized Nivolumab Management Clinical Trial page.